Search your stocks

Share

Profile

AARTIDRUGSAarti Drugs Ltd.

528.05(+2.21%)

1W: +4.94%

1M: +7.30%

1Y: +12.95%

Financials

Charts

YoY Net Sales

Operating Margin

EPS Growth

Pros & Cons

POSITIVES

Revenue increased sharply in the latest quarter, indicating strong market demand.
Profit margins improved, showcasing better cost management and operational efficiency.
EPS growth signals enhanced shareholder value and profitability.

NEGATIVES

Expenses have risen consistently, suggesting potential cost pressures impacting profitability.
Net profit decreased in the latest quarter compared to the previous, raising concerns over sustainability.
Operating profit margins have shown volatility, indicating inconsistent performance.

Quarterly Results Data

Field	Trend	Sep 23	Dec 23	Mar 24	Jun 24	Sep 24	Dec 24	Mar 25	Jun 25
Revenue		641.54	605.94	619.99	555.34	598.33	556.60	676.76	590.51
Expenses		585.95	556.06	556.89	512.47	553.93	517.74	607.48	539.71
Operating Profit		55.59	49.88	63.10	42.87	44.40	38.86	69.28	50.80
Other Income		0.68	1.67	1.08	1.11	1.48	11.90	1.87	0.31
Interest		8.25	7.60	9.13	8.71	8.93	9.07	9.16	8.56
Depreciation		12.61	12.66	13.58	13.38	13.72	13.80	14.88	14.72
Profit Before Tax		56.27	51.55	64.18	43.98	45.88	50.76	71.15	51.11
Tax		16.67	14.84	16.87	10.71	10.92	13.67	8.38	-2.86
Net Profit		39.60	36.71	47.31	33.27	34.96	37.09	62.77	53.97
Eps in Rs		4.29	3.99	5.15	3.62	3.83	4.06	6.88	5.91